VAC087: A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M (clinicaltrials.gov) - Oct 22, 2026 - P2 | N=360 | Active, not recruiting | Sponsor: University of Oxford | Trial completion date: Dec 2026 ➔ Mar 2027 | Trial primary completion date: Dec 2026 ➔ Mar 2027
Trial completion date • Trial primary completion date • Infectious Disease • Malaria
|